Looking to the Future of Early Detection in Cancer: Liquid Biopsies, Imaging, and Artificial Intelligence
Clin Chem
.
2024 Jan 4;70(1):27-32.
doi: 10.1093/clinchem/hvad196.
Authors
Stefan Foser
1
,
Kenneth Maiese
2
,
Subba R Digumarthy
3
,
Joan Anton Puig-Butille
4
,
Christian Rebhan
5
Affiliations
1
Vice President, Head in Center of Diagnostics for Innovation Oncology, Siemens Healthcare Diagnostics Products GmbH, Cologne, Germany.
2
Vice President of Medical Affairs, Diagnostics Research, Development, and Innovation, Siemens Healthcare Diagnostics, Tarrytown, NY, United States.
3
Associate Professor of Radiology, Harvard Medical School, Attending Thoracic Radiologist, Massachusetts General Hospital, Boston, MA, United States.
4
Head of Molecular Biology CORE, Biomedical Diagnostic Center (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.
5
President, Scientific Business Units & Chief Medical Officer, Unilabs, Geneva, Switzerland.
PMID:
38175601
DOI:
10.1093/clinchem/hvad196
No abstract available
MeSH terms
Artificial Intelligence*
Diagnostic Imaging
Early Detection of Cancer
Humans
Liquid Biopsy
Neoplasms* / diagnostic imaging